The present study investigated the glycemic response to an acute high‐intensity interval training (HIIT) session (10 one‐minute intervals ≥90% HRmax interspersed with one‐minute of active recovery) versus a moderate‐intensity continuous… Click to show full abstract
The present study investigated the glycemic response to an acute high‐intensity interval training (HIIT) session (10 one‐minute intervals ≥90% HRmax interspersed with one‐minute of active recovery) versus a moderate‐intensity continuous training (MICT) session (30 min at 64%–76% HRmax) during pregnancy. Twenty‐four normoglycemic females with a singleton pregnancy (27.8 ± 4.7 weeks of gestation, 31.5 ± 4.1 years of age, body mass index: 25.2 ± 11.3) participated in a randomized crossover design study. A flash glucose monitor and accelerometer were worn continuously for 7 days recording glycemic response, physical activity, and sleep. Nutritional intake and enjoyment of the exercise were self‐reported. Average heart rate during exercise was higher for HIIT (82 ± 4% HRmax) compared with MICT (74 ± 4% HRmax; p < 0.001) and participants achieved a peak heart rate of 92 ± 3% during HIIT (range 85%–97% HRmax) compared with 81 ± 4% during MICT (p < 0.001). The change in glucose values from pre‐to‐postexercise were not different between conditions (HIIT: −0.62 ± 1.00 mmol/L; MICT: −0.81 ± 1.05 mmol/L; p = 0.300) with the exception that fewer individuals experienced postexercise hypoglycemia immediately following HIIT compared with MICT (8% versus 33% respectively; p = 0.041). Other glucose variables was not different between exercise protocols. Physical activity (p = 0.07) and caloric intake did not differ (p = 0.10). The majority of participants preferred HIIT (87.5%) and had greater perceived enjoyment compared to MICT (HIIT: 7.8 ± 1.5; MICT: 6.6 ± 2.0; p = 0.015). Sleep duration was 52 ± 73 min longer after participating in HIIT compared with the night prior (main effect for time p = 0.017); no significant changes for MICT. Overall, an acute session of HIIT appears to be well tolerated and demonstrates no adverse effects on maternal glycemic response.
               
Click one of the above tabs to view related content.